3.12
price down icon0.32%   -0.010
after-market Dopo l'orario di chiusura: 3.11 -0.01 -0.32%
loading
Precedente Chiudi:
$3.13
Aprire:
$3.1
Volume 24 ore:
1.23M
Relative Volume:
1.37
Capitalizzazione di mercato:
$231.60M
Reddito:
$6.96M
Utile/perdita netta:
$-46.51M
Rapporto P/E:
-18.18
EPS:
-0.1716
Flusso di cassa netto:
$-37.99M
1 W Prestazione:
+15.56%
1M Prestazione:
+28.40%
6M Prestazione:
-16.13%
1 anno Prestazione:
-77.87%
Intervallo 1D:
Value
$2.96
$3.35
Intervallo di 1 settimana:
Value
$2.34
$3.66
Portata 52W:
Value
$1.60
$16.55

Perspective Therapeutics Inc Stock (CATX) Company Profile

Name
Nome
Perspective Therapeutics Inc
Name
Telefono
509-375-1202
Name
Indirizzo
350 Hills Street, Suite 106, Richland
Name
Dipendente
91
Name
Cinguettio
Name
Prossima data di guadagno
2025-03-26
Name
Ultimi documenti SEC
Name
CATX's Discussions on Twitter

Confronta CATX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Medical Devices icon
CATX
Perspective Therapeutics Inc
3.12 200.42M 6.96M -46.51M -37.99M -0.1716
Medical Devices icon
ABT
Abbott Laboratories
133.94 231.14B 42.34B 13.50B 6.66B 7.71
Medical Devices icon
BSX
Boston Scientific Corp
102.83 154.60B 17.55B 2.03B 2.72B 1.37
Medical Devices icon
SYK
Stryker Corp
383.10 146.12B 23.22B 2.86B 3.58B 7.40
Medical Devices icon
MDT
Medtronic Plc
87.00 105.64B 33.54B 4.66B 5.19B 3.62
Medical Devices icon
EW
Edwards Lifesciences Corp
77.77 45.60B 5.54B 4.18B 623.10M 7.00

Perspective Therapeutics Inc Stock (CATX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-03-13 Iniziato H.C. Wainwright Buy
2025-03-07 Iniziato Scotiabank Sector Outperform
2024-11-25 Downgrade BofA Securities Buy → Neutral
2024-10-24 Iniziato UBS Buy
2024-10-01 Iniziato Wedbush Outperform
2024-09-25 Iniziato Truist Buy
2024-07-25 Iniziato BofA Securities Buy
2024-05-09 Iniziato Cantor Fitzgerald Overweight
Mostra tutto

Perspective Therapeutics Inc Borsa (CATX) Ultime notizie

pulisher
05:11 AM

151,610 Shares in Perspective Therapeutics, Inc. (NYSE:CATX) Acquired by Two Sigma Advisers LP - Defense World

05:11 AM
pulisher
04:27 AM

ProShare Advisors LLC Acquires 5,011 Shares of Perspective Therapeutics, Inc. (NYSE:CATX) - Defense World

04:27 AM
pulisher
Jun 04, 2025

Perspective Therapeutics (NYSE:CATX) Rating Increased to Moderate Buy at Royal Bank of Canada - Defense World

Jun 04, 2025
pulisher
Jun 04, 2025

Perspective Therapeutics (NYSE:CATX) Price Target Raised to $16.00 at Royal Bank of Canada - Defense World

Jun 04, 2025
pulisher
Jun 03, 2025

Perspective Therapeutics (CATX) Price Target Raised by RBC Capital | CATX Stock News - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Perspective Therapeutics (CATX) Gets a Buy from Scotiabank - The Globe and Mail

Jun 03, 2025
pulisher
Jun 03, 2025

RBC Capital Boosts Price Target for Perspective Therapeutics (CATX) | CATX Stock News - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Perspective Therapeutics Updates on Radiopharmaceutical Advancements - TipRanks

Jun 03, 2025
pulisher
Jun 03, 2025

RBC Capital raises Perspective Therapeutics stock price target to $16 By Investing.com - Investing.com Nigeria

Jun 03, 2025
pulisher
Jun 03, 2025

RBC Raises Price Target on Perspective Therapeutics to $16 From $15, Keeps Outperform, Speculative Risk - marketscreener.com

Jun 03, 2025
pulisher
Jun 03, 2025

RBC Capital raises Perspective Therapeutics stock price target to $16 - Investing.com

Jun 03, 2025
pulisher
Jun 03, 2025

Perspective Therapeutics, Inc. (NYSE:CATX) Shares Sold by Nuveen Asset Management LLC - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Perspective Therapeutics, Inc. (NYSE:CATX) Shares Acquired by Deutsche Bank AG - Defense World

Jun 03, 2025
pulisher
Jun 02, 2025

Two Sigma Investments LP Takes $2.08 Million Position in Perspective Therapeutics, Inc. (NYSE:CATX) - Defense World

Jun 02, 2025
pulisher
May 31, 2025

Perspective Therapeutics, Inc. (CATX) Reports Positive Results for NET Treatment Trial - Insider Monkey

May 31, 2025
pulisher
May 30, 2025

Perspective Therapeutics Highlights Updated Interim Data from its Ongoing Phase 1/2a Clinical Trial of [212Pb]VMT-?-NET at the 2025 ASCO Annual Meeting | CATX Stock News - GuruFocus

May 30, 2025
pulisher
May 30, 2025

Perspective Therapeutics Provides Updated Interim Results and Safety Findings for [212Pb]VMT-α-NET at ASCO 2025 - Nasdaq

May 30, 2025
pulisher
May 30, 2025

Perspective Therapeutics Highlights Updated Interim Data from its Ongoing Phase 1/2a Clinical Trial of [212Pb]VMT-α-NET at the 2025 ASCO Annual Meeting - Yahoo Finance

May 30, 2025
pulisher
May 30, 2025

Millennium Management LLC Buys New Stake in Perspective Therapeutics, Inc. (NYSE:CATX) - Defense World

May 30, 2025
pulisher
May 29, 2025

Neuroendocrine Tumors Market: Epidemiology, Therapies, - openPR.com

May 29, 2025
pulisher
May 28, 2025

Perspective Therapeutics Announces Voting Results By Investing.com - Investing.com Canada

May 28, 2025
pulisher
May 28, 2025

Perspective Therapeutics Holds Annual Stockholders Meeting - TipRanks

May 28, 2025
pulisher
May 28, 2025

Perspective Therapeutics Announces Voting Results - Investing.com

May 28, 2025
pulisher
May 28, 2025

Northern Trust Corp Acquires 13,115 Shares of Perspective Therapeutics, Inc. (NYSE:CATX) - Defense World

May 28, 2025
pulisher
May 26, 2025

Janus Henderson Group PLC Has $57,000 Stake in Perspective Therapeutics, Inc. (NYSE:CATX) - Defense World

May 26, 2025
pulisher
May 24, 2025

Perspective Therapeutics, Inc. (NYSE:CATX) Given Consensus Rating of “Buy” by Brokerages - Defense World

May 24, 2025
pulisher
May 22, 2025

Equities Analysts Offer Predictions for CATX Q1 Earnings - Defense World

May 22, 2025
pulisher
May 22, 2025

HC Wainwright Has Pessimistic Outlook of CATX Q3 Earnings - Defense World

May 22, 2025
pulisher
May 21, 2025

Perspective Therapeutics, Inc. (CATX): Analysts See 460% Upside Potential - MSN

May 21, 2025
pulisher
May 21, 2025

Head-To-Head Review: Avinger (NASDAQ:AVGR) and Perspective Therapeutics (NYSE:CATX) - Defense World

May 21, 2025
pulisher
May 20, 2025

Perspective Therapeutics’ SWOT analysis: rare disease stock faces clinical hurdles - Investing.com Nigeria

May 20, 2025
pulisher
May 18, 2025

Mercer Global Advisors Inc. ADV Invests $51,000 in Perspective Therapeutics, Inc. (NYSE:CATX) - Defense World

May 18, 2025
pulisher
May 15, 2025

Perspective Therapeutics Reports Q1 2025 Earnings - TipRanks

May 15, 2025
pulisher
May 14, 2025

Perspective Therapeutics (CATX) Rating Maintained, Price Target Lowered | CATX Stock News - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Truist Securities Adjusts Perspective Therapeutics Price Target to $8 From $10, Maintains Buy Rating - marketscreener.com

May 14, 2025
pulisher
May 13, 2025

Oppenheimer cuts CATX stock price target to $15, maintains Outperform By Investing.com - Investing.com South Africa

May 13, 2025
pulisher
May 13, 2025

Perspective Therapeutics Provides Recent Business Highlights and Reports 1Q 2025 Results | CATX Stock News - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Oppenheimer Trims Perspective Therapeutics Price Target to $15 From $16, Maintains Outperform Rating - marketscreener.com

May 13, 2025
pulisher
May 13, 2025

Perspective Therapeutics, Inc. (NYSE:CATX) Shares Acquired by Wells Fargo & Company MN - Defense World

May 13, 2025
pulisher
May 13, 2025

Oppenheimer cuts CATX stock price target to $15, maintains Outperform - Investing.com

May 13, 2025
pulisher
May 12, 2025

Perspective Therapeutics: Q1 Earnings Snapshot - The Washington Post

May 12, 2025
pulisher
May 12, 2025

Perspective Therapeutics Inc (CATX) Q1 2025 Earnings: EPS Loss of $0.25 Beats Estimate, Revenue of $0.3M Exceeds Expectations - GuruFocus

May 12, 2025
pulisher
May 12, 2025

Perspective Therapeutics Reports Q1 2025 Results and Updates - TipRanks

May 12, 2025
pulisher
May 12, 2025

Perspective Therapeutics Provides Recent Business Highlights and Reports 1Q 2025 Results - The Manila Times

May 12, 2025
pulisher
May 12, 2025

Perspective Therapeutics, Inc. Announces Clinical Updates and Recruitment Progress for Novel Radiopharmaceuticals Ahead of 2025 ASCO Meeting - Nasdaq

May 12, 2025
pulisher
May 12, 2025

Perspective Therapeutics (CATX) Prepares for Q1 Earnings Announcement - GuruFocus

May 12, 2025
pulisher
May 12, 2025

Perspective Therapeutics, Inc. (NYSE:CATX) Shares Sold by Barclays PLC - Defense World

May 12, 2025
pulisher
May 08, 2025

Mariner LLC Invests $150,000 in Perspective Therapeutics, Inc. (NYSE:CATX) - Defense World

May 08, 2025
pulisher
May 05, 2025

Perspective Therapeutics Inc (AMEX: CATX): Down -84.76% In 2025, Outlook Remains Negative - Stocksregister

May 05, 2025
pulisher
May 02, 2025

Legal & General Group Plc Has $155,000 Stock Holdings in Perspective Therapeutics, Inc. (NYSE:CATX) - Defense World

May 02, 2025
pulisher
May 01, 2025

Perspective Therapeutics to Participate in Upcoming May Investor Conferences - The Manila Times

May 01, 2025

Perspective Therapeutics Inc Azioni (CATX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$317.16
price down icon 0.64%
medical_devices STE
$243.58
price up icon 0.61%
medical_devices SNN
$30.30
price up icon 3.52%
$71.55
price up icon 0.59%
$85.74
price up icon 0.15%
medical_devices EW
$77.77
price down icon 0.10%
Capitalizzazione:     |  Volume (24 ore):